TIEGHI, Alessia
 Distribuzione geografica
Continente #
NA - Nord America 450
EU - Europa 138
AS - Asia 92
Totale 680
Nazione #
US - Stati Uniti d'America 443
DE - Germania 54
CN - Cina 43
SG - Singapore 27
TR - Turchia 20
IT - Italia 18
UA - Ucraina 18
RU - Federazione Russa 12
FR - Francia 10
GB - Regno Unito 10
CA - Canada 7
FI - Finlandia 6
SE - Svezia 5
BE - Belgio 3
ID - Indonesia 2
IE - Irlanda 1
LT - Lituania 1
Totale 680
Città #
Fairfield 70
Woodbridge 66
Cambridge 32
Chandler 31
Houston 30
Ashburn 28
Seattle 28
Santa Clara 23
Singapore 22
Wilmington 20
Jacksonville 16
Beijing 11
San Diego 10
Shanghai 9
Ann Arbor 8
New York 8
Izmir 6
Los Angeles 6
Nanjing 6
Addison 5
Milan 5
Princeton 5
Boardman 4
Dearborn 4
Toronto 4
Bremen 3
Brussels 3
London 3
Orange 3
Bologna 2
Ferrara 2
Jakarta 2
Jiaxing 2
Munich 2
Nanchang 2
Ottawa 2
Rome 2
Auburn Hills 1
Changsha 1
Clearwater 1
Cormeilles-en-Parisis 1
Dublin 1
Frankfurt am Main 1
Indiana 1
Istanbul 1
Jinan 1
Kilburn 1
Lappeenranta 1
Ningbo 1
Shenyang 1
Taizhou 1
Tianjin 1
Vancouver 1
Verona 1
Totale 502
Nome #
P2X7 receptor expression in evolutive and indolent forms of chronic B lymphocytic leukemia 145
Soluble urokinase-type Plasminogen Activator Receptor (suPAR) as an independent factor predicting worse prognosis and extra bone marrow involvement in multiple myeloma patients 133
Clinical importance of interphase cytogenetics detecting occult chromosome lesions in myelodysplastic syndromes with normal karyotype 127
Chronic lymphocytic leukemia with 6q- shows distinct hematological features and intermediate prognosis 119
Dendritic cells in acute promyelocytic leukaemia 117
Peripheral blasts are associated with responses to ruxolitinib and outcomes in patients with chronic-phase myelofibrosis 19
A Prognostic Model to Predict Ruxolitinib Discontinuation and Death in Patients with Myelofibrosis 15
Predictors of Response to Hydroxyurea and Switch to Ruxolitinib in HU-Resistant Polycythaemia VERA Patients: A Real-World PV-NET Study 14
Determinants of Covid19 disease and of survival after Covid19 in MPN patients treated with ruxolitinib 9
Totale 698
Categoria #
all - tutte 3.471
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.471


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202089 0 0 0 0 11 17 15 15 10 12 8 1
2020/202163 5 3 19 6 0 7 1 7 0 8 5 2
2021/202275 8 6 6 0 9 3 2 1 1 7 7 25
2022/202372 5 2 5 10 13 9 5 6 13 0 3 1
2023/202444 3 4 0 1 4 9 4 2 2 1 5 9
2024/202591 6 16 20 16 33 0 0 0 0 0 0 0
Totale 698